Search research articles
Contact Us
Filters
Showing results (181-190 of 361) with videos related to
Page
of 37
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2020
The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia
Delphine Verbeke, Sofie Demeyer, Cristina Prieto, et al.
Journal of Hematology & Oncology
|
January 20, 2017
Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Xavier Poiré, Myriam Labopin, Johan Maertens, et al.
Frontiers in Immunology
|
February 23, 2023
Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
Sophie Servais, Frédéric Baron, Chantal Lechanteur, et al.
Haematologica
|
March 28, 2024
Gut microbiome alterations at acute myeloid leukemia diagnosis are associated with muscle weakness and anorexia
Sarah A Pötgens, Violaine Havelange, Sophie Lecop, et al.
Immunology
|
December 17, 2009
Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity
Louis Y A Chai, Frank van de Veerdonk, Renoud J Marijnissen, et al.
American Journal of Hematology
|
January 10, 2023
Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Sebastian Giebel, Myriam Labopin, Thomas Schroeder, et al.
Haematologica
|
January 2, 2015
Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation
Christian Koenecke, Gudrun Göhring, Liesbeth C de Wreede, et al.
Journal of Clinical Microbiology
|
May 4, 2012
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis
Louis Y A Chai, Bart-Jan Kullberg, Elizabeth M Johnson, et al.
Leukemia Research
|
June 11, 2013
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies
Carlos Graux, Anne Sonet, Johan Maertens, et al.
American Journal of Hematology
|
November 21, 2018
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Page
of 37
Search research articles
Search
Showing results (181-190 of 361) with videos related to
Sort By:
Page
of 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2020
The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia
Delphine Verbeke, Sofie Demeyer, Cristina Prieto, et al.
Journal of Hematology & Oncology
|
January 20, 2017
Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Xavier Poiré, Myriam Labopin, Johan Maertens, et al.
Frontiers in Immunology
|
February 23, 2023
Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
Sophie Servais, Frédéric Baron, Chantal Lechanteur, et al.
Haematologica
|
March 28, 2024
Gut microbiome alterations at acute myeloid leukemia diagnosis are associated with muscle weakness and anorexia
Sarah A Pötgens, Violaine Havelange, Sophie Lecop, et al.
Immunology
|
December 17, 2009
Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity
Louis Y A Chai, Frank van de Veerdonk, Renoud J Marijnissen, et al.
American Journal of Hematology
|
January 10, 2023
Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Sebastian Giebel, Myriam Labopin, Thomas Schroeder, et al.
Haematologica
|
January 2, 2015
Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation
Christian Koenecke, Gudrun Göhring, Liesbeth C de Wreede, et al.
Journal of Clinical Microbiology
|
May 4, 2012
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis
Louis Y A Chai, Bart-Jan Kullberg, Elizabeth M Johnson, et al.
Leukemia Research
|
June 11, 2013
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies
Carlos Graux, Anne Sonet, Johan Maertens, et al.
American Journal of Hematology
|
November 21, 2018
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Page
of 37